SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
355.50    5.50 (1.57%)
Bid:
354.00
Ask:
358.00
Spread: 4.00 (1.13%)
Market Cap: £1.82b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Acquisition

22 Jun 2015 07:00

RNS Number : 7766Q
Caledonia Investments PLC
22 June 2015
 



 

 

 

CALEDONIA INVESTMENTS AGREES TO ACQUIRE SEVEN INVESTMENT MANAGEMENT

 

Caledonia Investments plc ("Caledonia") is pleased to announce that it has agreed to acquire a majority stake in Seven Investment Management ("7IM"), the provider of discretionary fund management, retail investment funds and platform services to UK investors, in a transaction which values the business at £100m.

 

7IM was established in 2002 by its co-founders, Chief Executive Officer, Tom Sheridan, and Head of Corporate Development, Justin Urquhart Stewart, along with their Chief Finance Officer, Charles Sparrow, and has grown from its seven founder members to a team of more than 190 people. At 30 April 2015, it had assets under management and administration of approximately £9.5bn.

 

Dependent on the date of completion, which is subject to the Financial Conduct Authority's approval, Caledonia will invest up to £77m in cash to acquire approximately 94% of 7IM Holdings Ltd ("7IM Holdings"), the controlling member of Seven Investment Management LLP which operates the 7IM business, from its current owners, Allied Zurich Holdings Ltd and Aegon UK plc. 7IM's management team will subscribe £5.0m for the remaining equity, with the balance of the purchase costs to be provided by £25m of bank debt, which Caledonia has agreed to underwrite in the event that this is not in place by completion.

 

For its financial year to 31 December 2014, 7IM Holdings reported profit before tax of £8.6m and gross assets of £42.9m.

 

Commenting on the acquisition, Duncan Johnson, Caledonia's Head of Unquoted Investments, said:

 

"Caledonia has a long history of investing in successful fund management businesses. We look forward to supporting Tom Sheridan and his team in building on 7IM's impressive growth record and strong investment performance to service an expanding UK wealth management market where there is a growing demand for multi-asset and multi-manager funds."

 

Tom Sheridan, 7IM's Chief Executive, commented:

 

"We are delighted to be partnering with Caledonia in the next phase of 7IM's development. Their investment philosophy and culture, as well as their attitude to longer term investment, are perfectly aligned with our own. This will enable us to continue our focus on, and development of, "doing the right thing" in our business, for not just our partners and staff, but of course most importantly our clients.

 

My colleagues are also pleased to have the opportunity to be providing further investment into the business alongside Caledonia. We have many exciting developments and ideas for our clients, 7IM and our industry, and having Caledonia as a partner will greatly help us in achieving some very exciting goals."

 

22 June 2015

For further information contact:

 

 

Caledonia Investments plc

+44 20 7802 8080

Will Wyatt,

Chief Executive

 

Stephen King,

Finance Director

 

Duncan Johnson,

Head of Unquoted Investments

Media contact:

Tulchan Communications

+44 20 7353 4200

Peter Hewer

 

END

 

Notes for editors:

 

Caledonia Investments plc

Caledonia is a self-managed investment trust company listed on the London Stock Exchange with net assets of approximately £1.6bn. The company maintains a concentrated portfolio of international quoted, unquoted and fund investments and has paid an increasing annual dividend for 48 years.

 

In the unquoted arena, Caledonia seeks to invest £25m to £100m in private companies, either on a majority or minority basis, providing a meaningful presence and growth capital supporting double-digit operating margins. Its current unquoted portfolio includes Park Holidays (a UK caravan parks operator), Cobehold (a European unquoted investment house), TGE Marine (a marine gas-engineering business based in Germany), The Sloane Club (a London residential club) and Choice Care Group (a UK learning disability care homes provider).

 

For additional information on Caledonia, please visit www.caledonia.com.

 

7IM

7IM was founded in 2002 by its current management team and specialises in multi-asset risk-rated investment, which it offers through discretionary fund management, asset management and self-invest services. At 30 April 2015, 7IM had assets under management and administration of approximately £9.5bn.

 

For additional information on 7IM, please visit www.7im.co.uk.

 

Transaction

Caledonia's investment in 7IM was led by Charlie Edwards, Duncan Johnson, Tim Lewis and Tarquin Wethered.

 

Macfarlanes (Stephen Drewitt) and N M Rothschild & Sons (Ed Griffin) respectively acted as legal and financial advisers to Caledonia. PricewaterhouseCoopers (Fredrik Johansson) provided commercial due diligence advice and Deloitte (Tim Haden) provided tax advice. KPMG (James Woolf) provided financial due diligence services.

 

Evercore (Ollie Clayton) and Clifford Chance (Alex Erasmus) respectively provided corporate finance and legal advice to Allied Zurich Holdings Ltd and Aegon UK plc.

 

Squire Patton Boggs (Nick Allen) provided legal advice to 7IM's management team.

 

 

 

Neither the contents of Caledonia's nor 7IM's websites, nor the contents of any website accessible from hyperlinks on these websites (or any other website) is incorporated into, or forms part of, this announcement.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQPGUPUQUPAGGG
Date   Source Headline
27th May 20217:00 amRNSFinal Results
7th May 202111:39 amRNSNet Asset Value(s)
6th May 20218:13 amRNSHolding(s) in Company
9th Apr 20219:01 amRNSUnaudited net asset value and portfolio update
25th Mar 20215:45 pmRNSHolding(s) in Company
17th Mar 202110:03 amRNSDisposal
5th Mar 202112:27 pmRNSNet Asset Value(s)
16th Feb 20219:01 amRNSDirector Declaration
4th Feb 20219:11 amRNSNet Asset Value(s)
8th Jan 202110:39 amRNSNet Asset Value and Portfolio Update
7th Dec 202010:50 amRNSNet Asset Value(s)
27th Nov 20207:00 amRNSResult of Audit Tender
24th Nov 20207:00 amRNSHalf-year Report
6th Nov 202010:17 amRNSNet Asset Value(s)
7th Oct 202012:00 pmRNSNet Asset Value(s)
23rd Sep 20203:37 pmRNSDirector/PDMR Shareholding
22nd Sep 20209:13 amRNSHolding(s) in Company
21st Sep 20203:02 pmRNSDirector/PDMR Shareholding
4th Sep 20202:40 pmRNSNet Asset Value(s)
6th Aug 20204:08 pmRNSNet Asset Value(s)
5th Aug 20204:15 pmRNSDirector/PDMR Shareholding
5th Aug 20201:57 pmRNSDirector/PDMR Shareholding
29th Jul 20204:36 pmRNSResult of AGM
15th Jul 202010:52 amRNSPortfolio Update
7th Jul 202010:41 amRNSNet Asset Value(s)
1st Jul 202012:32 pmRNSBlock listing Interim Review
24th Jun 20204:37 pmRNSAnnual Financial Report
5th Jun 20209:05 amRNSNet Asset Value(s)
1st Jun 20205:20 pmRNSDirector/PDMR Shareholding
27th May 20207:00 amRNSFinal Results
19th May 20205:28 pmRNSDirector Declaration
7th May 20209:08 amRNSNet Asset Value(s)
30th Apr 20204:26 pmRNSDirector Declaration
28th Apr 20204:36 pmRNSPrice Monitoring Extension
27th Apr 20206:06 pmRNSDisclosure of rights attached to equity shares
7th Apr 20207:00 amRNSNet Asset Value(s)
30th Mar 20203:37 pmRNSHolding(s) in Company
20th Mar 20204:41 pmRNSPrice Monitoring Extension
20th Mar 202010:10 amRNSHolding(s) in Company
5th Mar 202011:24 amRNSNet Asset Value(s)
6th Feb 202010:47 amRNSNet Asset Value(s)
7th Jan 20209:53 amRNSNet Asset Value(s)
2nd Jan 20208:00 amRNSBlock listing Interim Review
20th Dec 20199:43 amRNSCompany Secretary Change
17th Dec 20198:05 amRNSDirector/PDMR Shareholding
6th Dec 201910:23 amRNSNet Asset Value(s)
28th Nov 201910:05 amRNSDirector/PDMR Shareholding
26th Nov 20197:00 amRNSHalf-year Report
22nd Nov 20193:40 pmRNSDirector Declaration
7th Nov 20199:13 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.